combining car-ts & bispecific antibodies
Published 2 years ago • 167 plays • Length 2:22Download video MP4
Download video MP3
Similar videos
-
4:27
the possibility of combining car-t therapy and bispecific antibodies in the treatment of nhl
-
6:38
the sequencing of cd19-targeting car-ts and cd20-targeting bispecifics in dlbcl
-
4:02
an overview of bispecifics in r/r myeloma and their integration into the treatment landscape
-
1:19
sequencing bispecific antibodies and car-t therapy & the evolving role of bispecifics in myeloma
-
2:52
replacing asct: car-t or bispecific antibodies?
-
2:38
weighing up the pros and cons of car-t therapy and bispecific antibodies in r/r dlbcl
-
12:15
car-t vs bispecific antibodies for lymphoma
-
2:37
efficacy of bispecific cd19/cd22 car t-cells in b-cell malignancies
-
9:11
chimeric antigen receptor car technique - creative biolabs (original version)
-
2:12
fully human anti-cd19 and cd22 bispecific tandem car-t
-
1:08
combining car-t with t cell-engaging bispecific antibodies to enhance efficacy in cll murine models
-
2:34
car-t & bispecific antibodies in second-line dlbcl
-
1:14
the car t-cell strategy vs bispecific antibodies
-
0:57
access to bispecifics and car-ts for multiple myeloma in brazil
-
1:42
how to best sequence bispecific antibodies and car-t therapy in multiple myeloma
-
2:16
the sequencing of novel therapies in myeloma (car-t, bispecifics, antibody-drug conjugates)
-
1:25
strategies to improve the efficacy of car-ts in cll
-
2:36
a cd38-targeting bispecific antibody in the treatment of r/r t-all
-
3:37
bispecific antibodies in multiple myeloma: their current role and the future
-
1:13
the future of car t-cells and bispecific antibodies to treat myeloma
-
4:35
bispecific antibodies vs car t-cells for r/r multiple myeloma